STRS Ohio’s Atea Pharmaceuticals AVIR Stock Holding History

STRS Ohio’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$547K	Buy	117,700 +21,300	+22%	+$106K	﹤0.01%	1104
2026 Q1	$519K	Sell	96,400 -17,100	-15%	-$78.5K	﹤0.01%	1066
2025 Q4	$405K	Hold	113,500	–	–	﹤0.01%	1180
2025 Q3	$329K	Hold	113,500	–	–	﹤0.01%	1292
2025 Q2	$409K	Buy	113,500 +8,000	+8%	+$23.9K	﹤0.01%	1399
2025 Q1	$315K	Hold	105,500	–	–	﹤0.01%	1384
2024 Q4	$353K	Hold	105,500	–	–	﹤0.01%	1326
2024 Q3	$353K	Hold	105,500	–	–	﹤0.01%	1399
2024 Q2	$349K	Buy	105,500 +10,800	+11%	+$40.3K	﹤0.01%	1388
2024 Q1	$382K	Sell	94,700 -6,000	-6%	-$23.5K	﹤0.01%	1362
2023 Q4	$307K	Hold	100,700	–	–	﹤0.01%	1451
2023 Q3	$302K	Hold	100,700	–	–	﹤0.01%	1452
2023 Q2	$376K	Buy	100,700 +5,500	+6%	+$20.6K	﹤0.01%	1393
2023 Q1	$318K	Sell	95,200 -32,700	-26%	-$133K	﹤0.01%	1485
2022 Q4	$615K	Buy	127,900 +36,800	+40%	+$186K	﹤0.01%	1197
2022 Q3	$518K	Sell	91,100 -3,900	-4%	-$29.9K	﹤0.01%	1317
2022 Q2	$674K	Sell	95,000 -28,700	-23%	-$196K	﹤0.01%	1166
2022 Q1	$893K	Buy	123,700 +25,700	+26%	+$175K	﹤0.01%	1106
2021 Q4	$876K	Buy	98,000 +60,200	+159%	+$938K	﹤0.01%	1196
2021 Q3	$1.32M	Buy	37,800 +700	+2%	+$19.4K	0.01%	938
2021 Q2	$796K	Buy	37,100 +28,900	+352%	+$868K	﹤0.01%	1341
2021 Q1	$506K	Buy	8,200 +4,700	+134%	+$318K	﹤0.01%	1566
2020 Q4	$146K	Buy	+3,500	New	+$113K	﹤0.01%	1812

Other funds holding AVIR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

STRS Ohio's AVIR Position: Q2 2026 in Review

STRS Ohio increased its Atea Pharmaceuticals (AVIR) stake by 22% in Q2 2026, buying an estimated $106K and bringing the position to 117,700 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

STRS Ohio first reported a position in AVIR in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.32M in Q3 2021. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

STRS Ohio held 117,700 shares of Atea Pharmaceuticals worth $547K as of Q2 2026.
STRS Ohio bought 21,300 Atea Pharmaceuticals shares in Q2 2026, an estimated $106K.
Atea Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1104 holding.
STRS Ohio first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
STRS Ohio's Atea Pharmaceuticals position peaked at $1.32M in Q3 2021.
125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.